| scholarly article | Q13442814 |
| P2093 | author name string | Hetian Lei | |
| Patricia A D'Amore | |||
| Gaoen Ma | |||
| Guohong Zhou | |||
| Wenyi Wu | |||
| Yajian Duan | |||
| Cindy Park-Windhol | |||
| P2860 | cites work | Src Family Kinases Promote Vessel Stability by Antagonizing the Rho/ROCK Pathway | Q57372719 |
| In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract | Q83181157 | ||
| Signal transduction by vascular endothelial growth factor receptors | Q84520249 | ||
| Combination therapy for the treatment of ocular neovascularization | Q36764604 | ||
| Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis | Q37175153 | ||
| Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation | Q37682513 | ||
| Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls | Q37722658 | ||
| Homing Endonucleases: From Microbial Genetic Invaders to Reagents for Targeted DNA Modification | Q37827234 | ||
| TAL effectors: customizable proteins for DNA targeting | Q37940951 | ||
| Mechanisms and regulation of endothelial VEGF receptor signalling. | Q38909541 | ||
| GPER mediates activation of HIF1α/VEGF signaling by estrogens | Q38988553 | ||
| The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells | Q39720539 | ||
| Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation | Q39819854 | ||
| Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells | Q39898210 | ||
| Genome editing abrogates angiogenesis in vivo | Q40109925 | ||
| Structures of the CRISPR genome integration complex | Q40114138 | ||
| p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. | Q40571016 | ||
| An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. | Q41396968 | ||
| N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy | Q41526638 | ||
| Temporal requirement of RPE-derived VEGF in the development of choroidal vasculature | Q42087568 | ||
| CRISPR-Cas9: Prospects and Challenges | Q42426695 | ||
| Regulating angiogenesis at the level of PtdIns-4,5-P2. | Q42532910 | ||
| Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 | ||
| Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors | Q24538483 | ||
| Safety and efficacy of gene transfer for Leber's congenital amaurosis | Q24634724 | ||
| Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo | Q24648140 | ||
| Therapeutic genome editing: prospects and challenges | Q28087380 | ||
| Axl is essential for VEGF-A-dependent activation of PI3K/Akt | Q28116976 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition | Q28238040 | ||
| Development and applications of CRISPR-Cas9 for genome engineering | Q28241526 | ||
| Genome editing. The new frontier of genome engineering with CRISPR-Cas9 | Q28252298 | ||
| Effect of gene therapy on visual function in Leber's congenital amaurosis | Q28277981 | ||
| Essential role for the p110delta phosphoinositide 3-kinase in the allergic response | Q28288981 | ||
| Genome editing with engineered zinc finger nucleases | Q28290795 | ||
| RNA-guided gene activation by CRISPR-Cas9-based transcription factors | Q28295458 | ||
| Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate | Q28301966 | ||
| High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis | Q28594191 | ||
| Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity | Q29615792 | ||
| In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
| The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 | ||
| Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response | Q30275154 | ||
| A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor | Q31104595 | ||
| Vesicle-associated membrane protein 2 (VAMP2) but Not VAMP3 mediates cAMP-stimulated trafficking of the renal Na+-K+-2Cl- co-transporter NKCC2 in thick ascending limbs | Q34140945 | ||
| Identification of PDGFR as a receptor for AAV-5 transduction | Q34264144 | ||
| Angiogenesis-dependent diseases and angiogenesis therapy | Q34310550 | ||
| RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology | Q34465364 | ||
| Circadian organization of the mammalian retina | Q34687175 | ||
| Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1 | Q35065442 | ||
| Improved vectors and genome-wide libraries for CRISPR screening | Q35215629 | ||
| In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 | Q35820051 | ||
| Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer | Q35958869 | ||
| Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor | Q36681701 | ||
| A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype | Q36715338 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | CRISPR | Q412563 |
| Cas9 | Q16965677 | ||
| CRISPR-Cas method | Q17310682 | ||
| P304 | page(s) | 6082-6090 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro | |
| P478 | volume | 58 |
| Q90484087 | Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening |
| Q57171979 | CRISPR/Cas9 genome surgery for retinal diseases |
| Q58579972 | Diabetic Retinopathy: A complex pathophysiology requiring novel therapeutic strategies |
| Q97567741 | Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update |
| Q92262796 | Precise CCM1 gene correction and inactivation in patient-derived endothelial cells: Modeling Knudson's two-hit hypothesis in vitro |
| Q55078229 | The Janus Face of VEGF in Stroke. |
Search more.